Top section
Top section
Bpifrance pounces to sell Technip block after shares leap
Europe’s self-proclaimed investment banking champions are playing to their strengths, but remain far behind US peers
The most successful investment banks must strive for excellence in managing people
More articles
More articles
More articles
-
It felt like a great weight had been lifted from financial markets this week. Two weights in fact. -
Hope of a Covid-19 vaccine ignited risk appetite for equity and corporate credit this week, as companies in struggling sectors enjoyed soaring share prices and printed bonds through fair value, write Mike Turner, Sam Kerr and Aidan Gregory.
-
Jefferies has enjoyed a record year in European investment banking, powered by equity capital markets, writes David Rothnie.
-
-
Rolls-Royce, the UK aerospace company, completed its rights issue on Thursday, with the cash call proving to be a resounding success. The deal benefited from a late boost on Monday, when US drug company Pfizer said it had enjoyed successful late-stage trials for a Covid-19 vaccine, giving investors hope that Rolls-Royce engines would be powering more planes into the sky sooner than expected.
-
Gland Pharma has completed India’s largest pharmaceutical IPO, a Rp65bn ($870.6m) deal that sailed through on demand from institutional accounts. But the issuer’s Chinese ties and a wobble in pharma stocks blunted retail investor interest. Jonathan Breen reports.
Sub-sections
shared comment list
